Become a member
Menu Back toSession 6: Enforcement Insights to Navigate Decision-Making

Advertising and Promotion Regulatory Affairs Conference

This event is now offered in a new entirely virtual format.

Session 6: Enforcement Insights to Navigate Decision-Making

Session Chair(s)

Kimberly Belsky, MS

Kimberly Belsky, MS

  • Executive Director, Regulatory Policy and Intelligence, Regulatory Affairs
  • Mallinckrodt Pharmaceuticals, United States
While the advertising and promotion regulations have not changed, areas of enforcement can evolve. Understanding current enforcement actions can help to navigate the complexities of risk-based decision-making. This session will provide insights and key learnings into recent FDA enforcement and potential impact beyond FDA (e.g., FTC, State AG’s, Lanham Act, private litigants).
Learning Objective : At the conclusion of this session, the participant should be able to:
  • Understand current enforcement trends and their impact
  • Articulate impact beyond FDA enforcement
  • Apply learnings and insights to decision making

Speaker(s)

Kimberly Belsky, MS

Speaker

Kimberly Belsky, MS

  • Executive Director, Regulatory Policy and Intelligence, Regulatory Affairs
  • Mallinckrodt Pharmaceuticals, United States
Francis Nguyen, PharmD

OPDP Enforcement Insights-Select Learnings

Francis Nguyen, PharmD

  • Assistant Director, Regulatory Advertising & Promotion
  • Bayer Healthcare Pharmaceuticals, United States
Heather E Rennie, JD

Is Private Enforcement the Answer: Lanham Act and Other Private Actions

Heather E Rennie, JD

  • Executive Director, Managing Counsel, US Commercial Legal
  • Merck Sharp & Dohme Corp., United States

Contact us

Registration Questions?

Send Email
1.888.257.6457

Preconference Primer

Drug and Medical Device Ad Promo Primer

On Demand Content Preview Webinar

Ad/Promo eCTD Submissions Round Table

Additional Information

Advertising and Promotion Regulatory Affairs Resource Kit

View Infographic